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Abstract
Objectives Investigation of DNA damage induced by CT x-
rays in paediatric patients versus patient dose in a multicentre
setting.
Methods From 51 paediatric patients (median age, 3.8 years)
who underwent an abdomen or chest CT examination in one
of the five participating radiology departments, blood samples
were taken before and shortly after the examination. DNA
damage was estimated by scoring γ-H2AX foci in peripheral
blood T lymphocytes. Patient-specific organ and tissue doses
were calculated with a validated Monte Carlo program. Indi-
vidual lifetime attributable risks (LAR) for cancer incidence
and mortality were estimated according to the BEIR VII risk
models.
Results Despite the low CT doses, a median increase of 0.13
γ-H2AX foci/cell was observed. Plotting the induced γ-
H2AX foci versus blood dose indicated a low-dose hypersen-
sitivity, supported also by an in vitro dose–response study.
Differences in dose levels between radiology centres were
reflected in differences in DNA damage. LAR of cancer
mortality for the paediatric chest CT and abdomen CT cohort
was 0.08 and 0.13‰ respectively.
Conclusion CT x-rays induce DNA damage in paediatric
patients even at low doses and the level of DNA damage is
reduced by application of more effective CT dose reduction
techniques and paediatric protocols.
Key Points
• CT induces a small, significant number of double-strand
DNA breaks in children.
• More effective CT dose reduction results in less DNA
damage.
• Risk estimates based on the LNT hypothesis may represent
underestimates.
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Introduction
The introduction of computed tomography (CT) has tremen-
dously improved diagnostic imaging. However, the high x-ray
doses associated with CT procedures have raised health con-
cerns [1]. This is of particular importance for the paediatric
patient population, recognized as one of the most important
target groups in medical radiation protection. Technological
developments in CT have substantially increased diagnostic
applications and accuracy in paediatric patients. Children have
a higher radiosensitivity compared to adults regarding x-ray-
induced malignancies and the associated risk for exposure-
induced death [2]. Therefore, optimisation and justification of
CT protocols for children is a topic of high importance in daily
clinical practice [3]. An initiative worth mentioning in this
context is the Image Gently campaign of the Alliance for
Radiation Safety in Paediatric Imaging, which tries to change
practice by increasing awareness of the opportunities to re-
duce radiation dose in the imaging of children [4]. Several
studies have shown that the use of CT dose reduction tech-
niques in paediatric CT imaging lowers the physical radiation
dose [5, 6]. However it remains unexplored if they also have
an impact on the DNA damage induced by CT x-rays in
children.
A recent study in the UK linked the exposure from x-rays
in CT imaging during childhood to the development of brain
tumours and leukaemia [7]. However, the risk assessments at
low doses remain subject of active debate. The lifespan study
(LSS) of atomic bomb survivors showed a roughly linear
relationship between cancer mortality and high doses of high
dose rate radiation for an adult population [8]. This resulted in
the linear-no-threshold (LNT) hypothesis, implying a linear
relationship between dose and biological effect without a dose
threshold. Despite the considerable uncertainties and diver-
gent views regarding the health effects and applicability of the
LNT theory at low doses, the model is used for risk estimation
by the international radiation protection community and re-
ferred to as the main paradigm of radiation protection [9].
The use of sensitive biomarkers for the assessment of early
x-ray effects in patients gives valuable information on dose–
effect relationships for diagnostic x-rays. Earlier work dem-
onstrated that the γ-H2AX foci assay can be used to determine
the effects of CT exposure at the molecular level, namely the
induction of DNA double-strand breaks (DSBs) [10–13].
DSBs are considered to be the most deleterious cellular effects
of x-rays, because they can result in loss or rearrangement of
genetic information, leading to cell death or carcinogenesis
[14]. The phosphorylation of the histone variant H2AX is one
of the earliest stages in the cellular response to DSBs and one
γ-H2AX focus represents one DNA DSB, which can be
quantified by immunofluorescence microscopy [15].
A prospective multicentre study was set up in order to
determine the number of x-ray-induced DNA DSBs in chil-
dren undergoing a chest or abdomen CTexamination. Herein,
the γ-H2AX foci assay was used as an effect biomarker for
radiation-induced DSBs. Blood doses were determined by a
patient-specific full Monte Carlo dose simulation in order to
correlate the induced DNA damage with the individual blood
dose. BEIR VII age- and gender-specific risk models were
used to assess the lifetime attributable risk (LAR) of cancer
incidence and mortality associated with the CTexamination of
every individual patient.
Materials and methods
Assessment of DNADSBs in pre- and post-CT blood samples
of paediatric patients
Study population
The study population consisted of 51 children undergoing a
CT examination of the chest (41) or abdomen (10) in one of
the five participating radiology centres (March 2012 through
July 2013) (Table 1). The small number of abdomen CT
patients was because magnetic resonance imaging (MRI)
was the preferred imaging modality of the majority of partic-
ipating radiologists for abdomen investigations, to avoid ion-
izing radiation exposure. Exclusion criteria were present or
past leukaemia or lymphoma and radiochemotherapy within
the last year. Themedian age of the patient groupwas 3.8 years
Table 1 Demographic data of the paediatric patients included in the
study
Chest CT Abdomen CT
Age (years) 3.00 (0.10–12.20) 7.1 (1.80–12.10)
Weight (kg) 13.50 (2.40–40.00) 24.00 (8.80–68.50)
Length (cm) 93.50 (45.50–160.00) 123.50 (76.50–167.00)
Men 30 7
Women 11 3
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(range 0.1–12.5 years). Before blood sampling, an informed
consent was signed by one of the parents of the children. The
prospective multicentre study was approved by the local re-
view boards of the participating hospitals, and the institutional
review board of Ghent University Hospital acted as central
ethical committee.
CT equipment and acquisition protocols
All the participating radiology departments used contempo-
rary state-of-the-art low dose CT systems. The following CT
systems were used in this study: Siemens SomatomDefinition
Flash and Sensation 64 (Siemens Medical Solutions, Germa-
ny), Toshiba Aquilion (Toshiba Medical Systems, Japan) and
three centres used the GE Discovery CT750 HD (GE
Healthcare, USA). Every radiology department used its own,
optimized paediatric CT protocol with low kVp settings (me-
dian values: chest CT 80 kV, range 80–120 kV; abdomen CT
100 kV, range 100–120 kV), low fixed tube currents or auto-
matic tube current modulation (ATM), adapted pitch values
and imaging lengths restricted to the region of interest. Itera-
tive reconstruction technology was applied in two of the
institutions, resulting in ultra-low doses (VEO reconstruction
from GE Healthcare). Individual CT parameters for the pa-
tients of the study are presented in Tables 2 and 3 for chest CT
and abdomen CT respectively. The combination of state-of-
the-art CT systems with dose reduction techniques and
adapted paediatric protocols resulted in low- or even
ultra-low CT doses.
Sample collection
Blood samples (2 mL) were collected through the catheter for
contrast agent administration. One blood sample was taken
before CT, to determine the baseline level of DSBs, and one
approximately 5 min after the examination (the catheter was
always flushed before sampling). As a result of occlusion,
blood sampling through the catheter was not possible for more
than half of the patients, especially very young children. For
these patients an additional venepuncture after the CT exam
was necessary. The blood samples were kept at 37 °C for
30 min to allow DNA damage signalling. Afterwards, DNA
repair was arrested by cooling the samples at 0 °C for 15 min.
Blood was transported at 4 °C, with an elapsed time no longer
than 3 h from collection to processing. Before processing,
samples were coded allowing blind scoring later on.
Detection of DNA DSBs
The method is based on the phosphorylation of the histone
variant H2AX after DSB formation and follows previously
published protocols [11, 16, 17]. In order to be able to work
with a homogeneous cell population, T lymphocytes were
isolated from the blood with the RosetteSep human T cell
enrichment cocktail (StemCell Technologies, France) and re-
suspended in complete RPMI cell culture medium (84 %
RPMI-1640, 15 % foetal calf serum, 1 %L-glutamine, 50
U/mL penicillin and 50 μg/mL streptomycin; Life Technolo-
gies, Belgium). For immunofluorescence staining, 250 μL of
the resuspended T lymphocytes was centrifuged onto poly-L-
lysine-coated slides (VWR International, Belgium). The slides
were fixed in 3 % paraformaldehyde (PFA) (Sigma-Aldrich,
Belgium) for 20 min and stored overnight in 0.5 % PFA.
Fixation should immobilize antigens while retaining the lym-
phocytes as close to their natural state as possible. The
next day, slides were permeabilised by dropping 100 μL
of 0.2 % Triton-X-100 (Sigma-Aldrich, Belgium). This
permeabilisation step is required because the anti-γ-H2AX
antibody binding requires intracellular access to detect the γ-
H2AX protein. The immunofluorescence staining was per-
formed with an unlabelled primary mouse monoclonal
anti-γ-H2AX antibody (1:500; Biolegend, Belgium) which
specifically binds to the target γ-H2AX protein, followed by
a secondary rabbit anti-mouse (RAM)–TRITC antibody
(1:1,000; DakoCytomation, Denmark). This secondary anti-
body carries the (TRITC) fluorophore, recognizes the primary
anti-γ-H2AX antibody and binds to it. Subsequently, the
lymphocyte nucleus was counterstained with 2 % 4′,6-
diamidino-2-phenylindole (DAPI) in Slowfade mounting me-
dium (Sigma-Aldrich, Belgium). DAPI is a blue fluorescent
stain specific for DNA. Microscopic scoring was performed
manually with an Olympus BX60 fluorescence microscope
with an Olympus×100/1.30 oil lens. The images were viewed
using Cytovision software and captured with a digital camera
(Applied Imaging, USA). Ten optical sections were obtained
for each field of vision (Z-stack sections of 1.03 μm). Differ-
ent images of one blinded slide were stored and on average
250 cells were scored manually for γ-H2AX foci. More than
250 cells were scored for every condition and the number of
γ-H2AX foci induced by CT x-rays was obtained by
subtracting the pre-scan foci yield from the post-scan foci
yield after decoding. The scoring procedure was validated
by double immunostaining for both γ-H2AX and p53 binding
protein 1 (53BP1), to discriminate between background arte-
facts and small γ-H2AX foci. The experiments demonstrated
that the γ-H2AX-TRITC foci coincide with 53BP1-FITC
foci, resulting in a statistical significant agreement between
the number of double stained foci (merge) and the number of
individual γ-H2AX-TRITC foci (results not shown).
In vitro dose–response study on umbilical cord blood samples
For the validation of the in vivo results, a set of in vitro
experiments was performed. Unfortunately, it was not possi-
ble to have access to blood samples with a larger volume than
2 mL from young children, because of ethical constraints.
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Since umbilical cord blood is physiologically and genetically
part of the foetus, we can consider this as blood of a newborn
[18]. Therefore, umbilical cord blood samples were irradiated
in vitro in order to compare the γ-H2AX foci dose response
Table 2 Individual CT parameters for all paediatric patients of the present study undergoing a chest CT examination
Patient number Tube current
(mA)
Exposure
time (s)
Tube voltage
(kV)
Pitch Collimation
(mm)
Type of CT scanner
1A 80 0.4 100 1.375 40 GE Discovery CT750 HD
1B* 60 0.4 100 1.375 40 GE Discovery CT750 HD
2 80 0.4 80 1.375 40 GE Discovery CT750 HD
3 35 0.6 100 1.375 40 GE Discovery CT750 HD (VEO)
4 30 0.4 100 0.984 40 GE Discovery CT750 HD
5 25 0.6 100 0.984 40 GE Discovery CT750 HD
6 38.3 (ATM) 0.5 80 1.375 40 GE Discovery CT750 HD
7 75 0.4 100 0.984 40 GE Discovery CT750 HD (VEO)
8 111.82 (ATM) 0.6 80 1.370 40 GE Discovery CT750 HD
9 86.86 (ATM) 0.6 80 1.375 40 GE Discovery CT750 HD
10 79 0.6 100 1.375 40 GE Discovery CT750 HD
11 94.98 (ATM) 0.6 120 1.375 40 GE Discovery CT750 HD
12 119.25 (ATM) 0.6 120 1.375 40 GE Discovery CT750 HD
13 22.47 (ATM) 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
14 22.58 (ATM) 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
15 18.90 (ATM) 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
16 31.54 (ATM) 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
17 10 0.4 80 0.984 40 GE Discovery CT750 HD (VEO)
18 41.42 (ATM) 0.4 80 0.984 40 GE Discovery CT750 HD (VEO)
19 19.66 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
20 61.69 (ATM) 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
21 24 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
22 37.67 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
23 39.15 (ATM) 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
24 31.13 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
25 10 0.4 80 0.984 40 GE Discovery CT750 HD (VEO)
26 35.84 (ATM) 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
27 21.58 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
28 29.81 (ATM) 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
29 33.30 (ATM) 0.4 80 0.516 40 GE Discovery CT750 HD (VEO)
30 122.32 (ATM) 0.285 120 0.900 38.4 Siemens Somatom Definition Flash
31 73.28 (ATM) 0.5 100 1.400 38.4 Siemens Somatom Definition Flash
32 163.19 (ATM) 0.5 100 1.200 38.4 Siemens Somatom Sensation 64
33 63.42 (ATM) 0.5 100 1.400 38.4 Siemens Somatom Definition Flash
34 124.31 (ATM) 0.5 100 1.400 38.4 Siemens Somatom Definition Flash
35 48.31 (ATM) 0.5 100 1.200 38.4 Siemens Somatom Definition Flash
36 160.54 (ATM) 0.5 100 1.200 38.4 Siemens Somatom Definition Flash
37 127.81 (ATM) 0.5 100 1.200 38.4 Siemens Somatom Definition Flash
38 89.89 (ATM) 0.5 100 1.200 38.4 Siemens Somatom Definition Flash
39 77.12 (ATM) 0.5 100 1.200 38.4 Siemens Somatom Definition Flash
40 157.67 (ATM) 0.5 80 1.200 38.4 Siemens Somatom Definition Flash
41 138.39 (ATM) 0.5 80 1.200 38.4 Siemens Somatom Definition Flash
ATM automatic tube current modulation, VEO iterative reconstruction
* Problems with contrast agent administration
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after in vivo and in vitro exposure. Cord blood samples from
three healthy donors were exposed to 1, 2, 4, 6, 8, 10, 15, 20
and 500 mGy and one blood sample was sham-irradiated. A
radiation quality of 100-kVp x-rays and 2-mm Al filtration
was used, with a PhilipsMG420 x-ray generator coupled to an
MCN420 tube. The irradiation was carried out in a 37 °C
water bath. Calibration was performed with an NE2571 Farm-
er ionization chamber (Thermo Electron, Altrincham, UK).
The irradiated blood samples were kept for 30 min at 37 °C,
followed by 15 min on ice water to simulate the situation of
patient blood samples after in vivo exposure. The same γ-
H2AX foci protocol and scoring method as described for the
in vivo study was applied. The use of cord blood for in vitro
experiments was approved by the institutional review board.
Patient dosimetry
Calculation of blood and organ doses induced by CT x-rays
by full Monte Carlo simulation
The blood dose was calculated as a weighted sum of doses to
the largest blood-containing organs with the percentage of
blood pool as weighting factor, namely lungs (12.5 %), heart
(10 %), liver (10 %) and remainder (67.5 %) [19]. In order to
obtain individual organ dose estimates, an individualized full
Monte Carlo patient dose simulation was set up using
ImpactMC simulation software 1.3.1 (CT Imaging GmbH,
Germany). In this software, patient-specific 3D voxel models
are created on the basis of the CT images acquired during CT
examination [20]. For the simulation of the CT scan, actual
scan parameters, such as tube voltage (kV), tube current–
exposure time product (mAs) and pitch, are retrieved from
the DICOM header of the CT images. The individual mA
values of all the reconstructed CT slices were used in order to
take into account of the tube current modulation of the CT
scanner. More than 1010 photons were simulated in order to
minimize the uncertainty in the Monte Carlo results. The
patient-specific dose distribution was determined by multiply-
ing the air kerma normalized dose distribution from the sim-
ulations with the actual air kerma value (mGy) measured free-
in-air in the isocentre of the scanner by using a pencil ioniza-
tion chamber (RaySafe Xi CT detector, Unfors RaySafe,
Sweden). In addition to the organ doses needed for the blood
dose evaluation, doses to other organs and tissues of interest
according to the BEIR VII risk models were also calculated
with thisMonte Carlo patient dose simulation. Organ volumes
were segmented in the original CT images and organ dose
deposition was calculated on the basis of the Monte Carlo
dose distribution. For the bone marrow, all bony structures in
the field of view were segmented and the bone marrow dose
was calculated as the weighted sum of the doses to these
structures with the percentage of bone marrow in these com-
partments as weighting factor [21]. To account for differences
in photon absorption in bone and bone marrow, the obtained
value was corrected for the ratio of mass absorption
coefficients in soft tissue and bone [22].
Calculation of effective dose
To compare the dose levels of the CT procedures in the current
study with similar procedures in different hospitals and coun-
tries, the effective dose was calculated for the total group of
chest CT and abdomen CT patients. Effective dose is a quan-
tity reflecting the stochastic risk associated with an exposure
to ionizing radiation at a population level. The effective doses
of the paediatric populations under study were derived from
Table 3 Individual CT parameters for all paediatric patients of the present study undergoing an abdomen CT examination
Patient number Tube current
(mA)
Exposure
time (s)
Tube voltage
(kV)
Pitch Collimation
(mm)
Type of CT scanner
1 70.5 0.6 100 1.375 40 GE Discovery CT750 HD
2 325 0.8 100 0.984 40 GE Discovery CT750 HD
3 120 0.5 100 0.844 32 Toshiba Aquilion
4A 188.63 (ATM) 0.5 120 0.900 38.4 Siemens Somatom Definition Flash
4B* 349.5 (ATM) 0.285 100 0.600 38.4 Siemens Somatom Definition Flash
5 184.21 (ATM) 0.5 100 0.900 38.4 Siemens Somatom Definition Flash
6A 49.7 (ATM) 0.5 100 1.200 38.4 Siemens Somatom Definition Flash
6B* 47.38 (ATM) 0.5 100 1.200 38.4 Siemens Somatom Definition Flash
7 152.32 (ATM) 0.5 100 1.200 38.4 Siemens Somatom Definition Flash
8 105.69 (ATM) 0.5 100 1.400 38.4 Siemens Somatom Definition Flash
9 122.55 (ATM) 0.5 100 1.400 38.4 Siemens Somatom Definition Flash
10 75.92 (ATM) 0.5 100 1.200 38.4 Siemens Somatom Definition Flash
ATM automatic tube current modulation
* One scan with and one scan without contrast agent administration
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the individual DLP values by using the conversion factors
published by Deak et al. as function of kVp, imaging region
and age for ICRP publication 103 recommendations [23].
Risk estimation
Individual LAR of cancer incidence and mortality relat-
ed to a chest or abdomen CT scan were calculated
according to the BEIR VII risk models for different
cancer types, taking into account age-dependent inci-
dence and mortality rates within the Euro-American
population [24]. Input for these risk assessments was
the simulated organ doses and the age of the individual
patients. The LAR data from BEIR VII were adapted
for a dose and dose-rate effectiveness factor of 2 as
proposed by the ICRP [25].
Statistical analysis
Statistical analysis was performed with Microsoft Office
Excel 2010 (Microsoft Corporation, USA) and Statistical
Package for Social Sciences software version 22 (SPSS
Inc., USA). Poisson statistics were applied to calculate
the statistical accuracy of the number of x-ray induced
γ-H2AX foci. The differences between the pre- and
post-CT data sets were evaluated for significance with
the paired sample Wilcoxon signed-rank test (95 %
confidence level). Linear regression analysis was applied
to evaluate age dependence. A p value less than 0.05
was considered as statistically significant.
Results
Assessment of DNADSBs in pre- and post-CT blood samples
of paediatric patients
An increase in DNA DSBs was observed for every patient,
except for one chest CT patient with a very low blood dose of
0.14 mGy. The median pre-exposure level was 0.56 foci/cell
(range 0.23–1.20 foci/cell) and the post-exposure level was
0.72 foci/cell (range 0.31–1.44 foci/cell). The pre- and post-
CT exposure foci levels are presented in Fig. 1 for every
individual patient. The median number of induced foci
representing DNA DSBs induced by CT was 0.13 foci/cell
(range −0.07 to 0.49 foci/cell) and the median blood dose
0.94 mGy (range 0.14–8.85 mGy). The present study shows
that nearly every CT procedure induces DNA DSBs in T
lymphocytes of paediatric patients. A Wilcoxon signed-rank
test showed a statistically significant difference in the mean
level of DNA DSBs pre-CT and the mean level post-CT per
patient (p<0.001). Moreover, the number of induced DSBs is
strongly blood dose dependent as illustrated in Fig. 2.
To investigate the intrinsic higher radiosensitivity of chil-
dren decreasing with age, the number of induced γ-H2AX
foci was divided by the calculated blood dose and plotted
versus age of the paediatric patient. The linear fit in Fig. 3
indicates a diminishing trend of the foci-to-dose ratio
versus age; however, regression analysis showed that
the decrease of the foci-to-dose ratio versus age was
not statistically significant (p=0.204).
In vitro dose–response study on umbilical cord blood samples
The results of the in vitro irradiation of umbilical cord
blood, repeated for three different donors, are also pre-
sented in Fig. 2. The in vivo and in vitro dose–response
curves show both an initial sharp increase with dose
and appear not linear at all. The dashed line in Fig. 2
represents an extrapolation according to the LNT hy-
pothesis of the in vitro dose response of γ-H2AX foci
in cord blood at doses (5.68 γ-H2AX foci/cell for
0.5 Gy) higher than zero. This shows clearly that the foci
numbers in the low dose range are much higher than expected
from the LNT extrapolation of high dose behaviour.
Patient dosimetry
Monte Carlo calculations resulted in a median blood
dose for chest CT patients of 0.86 mGy (0.14–
2.84 mGy) and for abdomen CT patients of 1.62 mGy
(0.66–8.85 mGy). The median effective dose value for
the chest CT patient cohort was 1.14 mSv (range 0.17–
3.10 mSv). For the abdomen CT patient cohort, the
median effective dose value was higher, namely
2.82 mSv (range 1.18–10.55 mSv). A comparison of
these values with literature data confirms that in the
present study patient doses were low [26, 27]. All
participating centres used state-of-the-art low dose
equipment and specific paediatric protocols, resulting
in very low CTDIvol and DLP values of the patients
compared with the national dose reference levels
(DRLs) (Table 4). Reference levels are typically set at
the 75th percentile of the dose distribution from a
conducted survey. The median CTDIvol and DLP values
in the current study are below the 75th percentile values
and close to the 25th percentile, which represents good
clinical practice. However, substantial differences in
dose-sparing equipment and imaging protocols for chil-
dren resulted in differences in patient doses and corre-
sponding DNA damage. Figure 4 shows a clear corre-
lation between both parameters when comparing the
data for the different participating hospitals. This figure
emphasizes that the use of more powerful dose
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reduction techniques and protocols involving a lower
patient dose also results in less radiation effects for
paediatric patients according to the DNA damage effect
biomarker.
Fig. 1 Comparison of γ-H2AX-foci levels pre- and post-CT x-ray exposure for every individual patient of the study. Error bars represent standard
deviations on foci yields calculated following Poisson statistics
Fig. 2 a The mean number of
γH2AX-foci per cell induced by
in vivo x-ray exposure plotted
versus the Monte Carlo calculated
blood dose for every paediatric
patient undergoing a chest CT or
abdomen CT (in blue). The
whiskers represent standard
deviations derived from the
statistical accuracy of the scored
number of foci in the blood
samples taken before and after CT
examination (Poisson statistics).
The dose–response curve after in
vitro x-ray irradiation of cord
blood is also shown (in green).
The whiskers of the in vitro study
represent SDs among the three
different donors. The dashed line
represents a linear extrapolation
based on the γ-H2AX foci
induced in cord blood after an in
vitro dose of 0.5 Gy, based on the
LNT hypothesis. Since a large
part of the data are clustered in
0–2 mGy range, this range is
presented as a separate figure (b)
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Risk estimation
Based on the Monte Carlo calculated organ doses, individual
LAR values for cancer incidence and mortality according to
the BEIR VII risk models were calculated for every patient.
The BEIR VII report provides a method to estimate LAR of
cancer incidence and mortality based on the organ doses
associated with the radiation exposure and a patient’s age at
the time of exposure. Table 5 represents the median LAR
values of cancer incidence and mortality related to leukaemia
and different types of solid cancer of organs in the field of
view based on the simulated organ doses. The range of LAR
values over the patient cohorts is indicated between brackets.
For the total patient cohort undergoing a chest CTexamination
the LAR values for cancer incidence and mortality are respec-
tively 0.17 per thousand and 0.08 per thousand. For the total
group of paediatric patients undergoing an abdomen CT ex-
amination the LAR incidence and mortality are respectively
0.32 per thousand and 0.13 per thousand.
Discussion
Our study provides evidence that CT induces DNA damage in
paediatric patients, even at low doses (blood doses in the range
of 0.15–8.85 mGy). Several studies reported γ-H2AX foci
induction by CT x-ray exposure in adult patients [10–13, 28].
However none of them investigated the DNA damage induced
by CT radiation exposure in paediatric patients, nor the ultra-
low dose region evaluated in the current study. Stephan et al.
conducted a small scale pilot study with blood samples from
ten paediatric patients undergoing CT examinations, in which
chromosome analysis in lymphocytes showed a significant
increase in dicentric frequencies and excess acentric fragments
[29]. However, the mean blood dose of the cohort of ten
children in that study was 12.9 mGy compared to the low
mean blood dose of 1.35mGy for the 51 patients in the current
study.
Currently, the vast majority of publications use the concept
of effective dose to assess CT radiation burden. However,
effective dose calculations can never be linked to an individual
patient exposure, as reference phantoms need to be used and
the quantity effective dose is designed for risk estimation in a
population. To interpret the in vivo γ-H2AX foci data, it is
very important to have an accurate blood dose calculation for
every patient, which takes into account the patient’s anatomy,
different types of CT systems, dose reduction technologies
and various types of CT protocols. However, the latter analy-
sis cannot be performed by using effective dose. This was
accomplished by a Monte Carlo simulation of radiation trans-
port in patient-specific 3D voxel models derived from the CT
images. For dosimetry of paediatric patients the use of voxel
models is a substantial improvement compared to dose calcu-
lation based on anthropomorphic paediatric standard phan-
toms, as the fullMonte Carlo simulation takes into account the
real anatomy of the patient.
Fig. 3 The number of γ-H2AX
foci normalized to blood dose, as
a function of age of the paediatric
patients. The dashed line is the
result of a linear fit
Table 4 Comparison of the median CTDIvol (mGy) and DLP (mGy cm)
values of the chest CT and abdomen CT investigations in this study with
the national DRLs (75th percentile) in Belgium. As an indication of good
clinical practice, the 25th percentile is also presented
Chest CT Abdomen CT
CTDIvol (mGy)
25th percentile 1.85 2.80
75th percentile (DRL) 5.00 6.75
Study data 1.54 (0.22–4.07) 4.17 (1.11–13.98)
DLP (mGy cm)
25th percentile 40.00 100.00
75th percentile (DRL) 130.00 315.00
Study data 24.80 (4.57–130.36) 315 (33.00–698.82)
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Fig. 4 The mean γ-H2AX foci
per cell induced by CT x-rays
plotted against the mean patient
blood dose for participating
centres. The CT equipment used
by the participating centres was as
follows: hospital A, GE
Discovery CT750 HD; hospital
B, GE Discovery CT750 HD
(VEO); hospital C, Siemens
Somatom Definition Flash and
Toshiba Aquilion; hospital D, GE
Discovery CT750 HD (VEO);
hospital E, Siemens Somatom
Definition Flash and Sensation
64. Whiskers represent the
standard deviation on the mean of
foci numbers and blood doses
Table 5 LAR of cancer incidence and mortality, according to the BEIR VII model, associated with x-ray exposure from chest CT and abdomen CT
examinations for the cohort of paediatric patients included in the study
LARincidence (‰) LAR mortality (‰) LARincidence (‰) LAR mortality (‰)
Chest CT
Men (30) Women (11)
Age (year) 3.20 (0.20–11.50) 2.00 (0.10–12.20)
Blood dose (mGy) 0.81 (0.14–2.84) 0.86 (0.55–2.56)
Stomach 0.007 (0.001–0.017) 0.004 (0.001–0.009) 0.011 (0.005–0.033) 0.006 (0.003–0.019)
Liver 0.005 (0.001–0.011) 0.003 (0.001–0.008) 0.002 (0.001–0.005) 0.002 (0.001–0.005)
Lung 0.034 (0.006–0.130) 0.035 (0.006–0.131) 0.088 (0.049–0.275) 0.077 (0.043–0.241)
Breast – – 0.159 (0.048–0.415) 0.037 (0.011–0.097)
Thyroid 0.011 (0.002–0.032) – 0.078 (0.043–0.141) –
Remainder 0.037 (0.005–0.094) 0.014 (0.002–0.034) 0.038 (0.020–0.146) 0.014 (0.008–0.055)
Leukaemia 0.002 (0.000–0.007) 0.001 (0.000–0.004) 0.002 (0.001–0.003) 0.001 (0.000–0.002)
All cancers 0.099 (0.015–0.287) 0.055 (0.009–0.184) 0.378 (0.171–1.016) 0.137 (0.067–0.417)
Abdomen CT
Men (7) Women (3)
Age (years) 7.10 (1.80–12.10) 7.90 (6.10–11.00)
Blood dose (mGy) 1.61 (0.66–8.85) 1.38 (1.09–4.15)
Stomach 0.018 (0.007–0.058) 0.009 (0.004–0.030) 0.010 (0.008–0.035) 0.006 (0.005–0.020)
Colon 0.089 (0.035–0.337) 0.043 (0.017–0.158) 0.045 (0.028–0.110) 0.021 (0.013–0.051)
Liver 0.014 (0.006–0.047) 0.010 (0.004–0.033) 0.005 (0.002–0.013) 0.004 (0.002–0.011)
Lung 0.018 (0.011–0.065) 0.018 (0.011–0.063) 0.067 (0.031–0.068) 0.059 (0.027–0.059)
Prostate 0.024 (0.004–0.075) 0.005 (0.001–0.032) – –
Uterus – – 0.008 (0.005–0.021) 0.002 (0.001–0.005)
Ovary – – 0.021 (0.009–0.042) 0.011 (0.005–0.023)
Bladder 0.054 (0.010–0.176) 0.012 (0.002–0.037) 0.039 (0.002–0.099) 0.011 (0.006–0.028)
Remainder 0.077 (0.015–0.274) 0.027 (0.005–0.096) 0.100 (0.029–0.273) 0.025 (0.012–0.071)
Leukaemia 0.008 (0.002–0.029) 0.003 (0.001–0.018) 0.005 (0.004–0.015) 0.002 (0.002–0.009)
All cancers 0.318 (0.091–1.047) 0.131 (0.046–0.445) 0.329 (0.263–0.677) 0.130 (0.108–0.277)
Values are median (range), based on the individual simulated organ doses and the age of the individual patients
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In addition the results of the present study show that lower
patient doses related to more effective CT dose reduction
strategies for paediatric patients also result in a similar de-
crease in DNA DSBs as effect biomarker. It is internationally
recognized that CT dose optimization is essential, especially
for children taking into account not only dose reduction but
also diagnostic image quality. A number of CT dose surveys
showed substantial differences between practices for the same
type of examination, suggesting that not all institutions have
suitably optimized their CT protocols [30, 31]. Dose-saving
strategies are continuously evolving in terms of imaging tech-
niques as well as dose management, and the results of the
present study stress the importance of dose reduction in pae-
diatric CT imaging. As already shown by the values of the
calculated blood doses and the comparison of DLP and
CTDIvol values with national DRLs, paediatric CT radiation
doses were substantially low in all participating radiology
departments. One of the institutions (hospital D in Fig. 4)
achieved very low doses (mean blood dose, 0.71 mGy) by
using iterative reconstruction for all CT examinations; how-
ever, only chest CT patients were recruited in this institution.
For the patient cohort of institution D, a very low mean level
of induced γ-H2AX foci per cell (0.10 foci/cell) was recorded.
Hospital E achieved a mean blood dose of 0.95 mGy corre-
sponding to 0.13 induced foci/cell, and the data for this
hospital are a mixture of chest CT and abdomen CT investi-
gations. For both types of examination DLP values in this
hospital were very low compared to the DRL (reported in
Table 4). The median DLP value for abdomen CT patients in
hospital E was 60.00 mGy cm (range 33.00–87.20 mGy cm),
which is lower than the 25th percentile of 100 mGy cm.
When the number of induced γ-H2AX foci is plotted
versus blood dose, the data point to a low-dose hypersensitiv-
ity. The observed low-dose hypersensitive response in paedi-
atric CT is consistent with the data of a previous study on
paediatric patients undergoing a cardiac catheterization [17].
The in vitro dose–response curve for umbilical cord blood
shows the same behaviour in the low dose range and supports
the in vivo results.
The observed low-dose hypersensitivity challenges the
LNT hypothesis, assuming less DNA damage, and can be
explained by the “bystander effect” [32]. Genetic/epigenetic
changes occur not only in cells hit by the ionizing particles but
also in non-irradiated cells that are neighbouring directly hit
cells. The bystander effect amplifies the effects of radiation by
increasing the number of affected cells, owing to cell–cell
communication or soluble factors released by irradiated cells.
Bystander effects are observed after co-cultivation of irradiat-
ed and non-irradiated cells and transfer of medium from
irradiated to non-irradiated cells [33, 34]. For cells in direct
contact, bystander signalling can occur through gap junction
intercellular communication [35, 36]. A second route by
which bystander responses are mediated is through the release
of soluble factors from cells that have been irradiated. These
factors have been extensively studied and several of these key
molecules are central players involved in stress responses and
cell–cell signalling, which are not generally specific to radia-
tion exposure [35]. Moreover, many aspects of bystander-
mediated response have close parallels to inflammatory re-
sponses. This was recently shown in a gene set enrichment
analysis that highlighted different gene expression profiles in
whole blood samples irradiated with low and high doses of x-
rays. Functional analysis of genes differentially expressed at
0.05 Gy showed the enrichment of chemokine and cytokine
signalling [37]. In a study by Mancuso et al., DNA damage,
apoptosis and tumour induction were observed in the shielded
cerebellum of mice heterozygous for Patched after partial-
body irradiations [38]. This indicates that bystander effects
in vivo have carcinogenic potential.
A possible confounder in the present study could be the
increase in DSB levels due to the administration of contrast
agent and the corresponding emission of secondary radiation
in CT imaging. However, previous studies showed that there
was no biological dose-enhancing effect if radiation and con-
trast agent are within the diagnostic range [11, 39].
Epidemiological data indicate a higher relative risk of
cancer per unit of radiation dose for children compared to
adults, and children have also a longer lifetime for radiation-
related cancer to occur [2]. We observed a non-significant age
dependency in our present study of x-ray-induced DNA
DSBs. To study age dependence, the study population should
be broadened and a more uniform distribution of the ages is
required.
Using the calculated organ doses, the LAR for cancer
mortality in the paediatric patient population undergoing a
low dose chest or abdomen CT was of the order of 0.1‰
according to the BEIRVII data assuming the LNT hypothesis.
The thyroid gland, breast tissue and gonads are structures that
have an increased sensitivity to radiation in growing children.
Some of these regions, such as thyroid and breast tissue, are
routinely involved in chest CT imaging. Miglioretti et al.
[27] calculated radiation exposure and LAR for cancer
incidence from a random sample of paediatric CTs. Their
calculated LARs are an order of magnitude higher than
those reported in the current study: abdomen CT 1–4‰
versus 0.3‰ (median), chest CT 2–3‰ versus 0.1–0.4‰
(median boys–girls). The main reason for the lower risk
estimates in the current study are lower patient doses
compared to the work of Miglioretti et al. [27]. They
reported a mean ED of 12.5 mSv for abdomen CT and
6.3 mSv for chest CT, whereas in the present work the
median ED values were 2.8 mSv and 1.1 mSv respec-
tively. The lower doses and corresponding risk estimates
in the current work reflect the use of contemporary state-
of-the-art low dose CT equipment and the successful
implementation of dose reduction strategies for paediatric
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CT imaging by the participating radiology departments
(as illustrated in Table 4).
Large uncertainties are associated with the risk estimates
summarized in Table 5. The BEIR VII committee estimates
that the excess cancer mortality due to radiation can be esti-
mated within a factor of 2 (at 95 % confidence level). For
leukaemia the corresponding factor is 4. The LNT model
applied by the BEIR VII committee is based mainly on epi-
demiological data for radiation-induced cancers in the atomic
bomb survivors in the dose range of about 100 mSv to 2.5 Sv
[8]. For lower doses involved in diagnostic radiology, epide-
miological data are not available to support the LNT model
mainly owing to the necessary sample size [40]. Application
of the LNT hypothesis in the low dose range may lead to an
overestimation of the risk in case of the existence of a dose
threshold or an underestimate in case of cooperative multicel-
lular radiation effects such as bystander effects. It is anticipat-
ed that significant insights into dose response and cancer risks
in the low dose range will emerge from molecular epidemiol-
ogy studies incorporating biomarkers and bioassays [41]. The
low-dose hypersensitivity observed in the γ-H2AX foci dose
response of the present study indicates that LAR estimates
based on the LNT model may potentially underestimate the
risks of paediatric CT imaging.
For conclusions with respect to the risk of stochastic effects
of x-rays, the present study has limitations. Biological damage
in T lymphocytes reflects only the damage in one tissue,
namely the blood. However, we may assume that DNA dam-
age and repair in peripheral blood lymphocytes are represen-
tative for other normal tissues [42]. Using the γ-H2AX foci
assay, only DNADSBs induced by CT x-rays are detected but
not the outcome of the DNA repair process. DNA DSBs are
considered to be particularly biologically important because
their repair is more difficult than other types of DNA damage.
Cells have evolved mechanisms to monitor genome integrity
and they respond to DNA damage by activating a complex
DNA damage response pathway. Erroneous repair of DNA
DSBs can result in chromosomal rearrangements, including
translocations, which are associated with tumorigenesis [43].
An increase in chromosomal aberrations due to a defect in
DNA repair, as observed in ataxia-telangiectasia (AT) patients,
leads to genetic instability, which in turn enhances the rate of
cancer development [44]. In the framework of cancer risk, a
direct assessment of mutations in DNA or chromosomal ab-
errations induced by CT x-rays in paediatric patients’ lym-
phocytes would provide added value taking into account the
mutagen–carcinogen link. However, this kind of study is not
obvious in view of the low sensitivity of contemporary muta-
genicity assays.
The present study emphasizes the need to optimize and
minimize radiation exposure in paediatric CT imaging: lower
patient doses entail less DNA damage in children. This im-
plies the need for justification of the indications for which
medical imaging involving ionizing radiation is used. From a
patient’s perspective, the benefits of a medically necessary CT
scan far exceed the small radiation-induced cancer risk. How-
ever, some studies suggest that a third of paediatric CT scans
are unnecessary [1]. This indicates that the referring physician
and radiologist should consider whether the exam is truly
clinically indicated and was not recently performed in another
hospital. Furthermore, they should check if no alternative
diagnostic procedure might be available, one not involving
ionizing radiation such as ultrasound and MRI. When CT is
indicated, great care should be taken to optimize radiation
exposures in order to minimize the risk for carcinogenic
effects later in life. Strategies to optimize radiation doses in
paediatric CT imaging are adjustment of the CT parameters to
the child’s size (guidelines on individual size/weight parame-
ters [45]), the scan length should be restricted to the region of
interest and dose reduction techniques should be implemented
taking into account the required image quality (ATM, iterative
reconstruction and/or adaptive collimation). The observations
of the present work should encourage medical practitioners to
maximize the benefit-to-risk ratio of CT imaging in paediatric
radiology.
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